The DOI matches its Crossref record; 225 of the 227 references it cites were found in a registry or an index, and 1 are not checked yet.
Tumor targeting via EPR: Strategies to enhance patient responses
Open accessAbstract
The tumor accumulation of nanomedicines relies on the enhanced permeability and retention (EPR) effect. In the last 5-10 years, it has been increasingly recognized that there is a large inter- and intra-individual heterogeneity in EPR-mediated tumor targeting, explaining the heterogeneous outcomes of clinical trials in which nanomedicine formulations have been evaluated. To address this heterogeneity, as in other areas of oncology drug development, we have to move away from a one-size-fits-all tumor targeting approach, towards methods that can be employed to individualize and improve nanomedicine treatments. To this end, efforts have to be invested in better understanding the nature, the complexity and the heterogeneity of the EPR effect, and in establishing systems and strategies to enhance, combine, bypass and image EPR-based tumor targeting. In the present manuscript, we summarize key studies in which these strategies are explored, and we discuss how these approaches can be employed to enhance patient responses.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source doesn’t support the claim as written.
In the citing paper
“They showed around 97% of the NPs are delivered to tumors by endothelial cells through an active process of transcytosis instead of passive transport.”
From Approaches to Improve EPR-Based Drug Delivery for Cancer Therapy and Diagnosis (2023) · cites this paper as [161]
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measuredThe cited source doesn’t support the claim as written.
In the citing paper
“A recent study by Chan W.C.W et al. demonstrated that inter-endothelial gaps in tumors may not be responsible for the transport of nanodrugs into solid tumors [161].”
From Approaches to Improve EPR-Based Drug Delivery for Cancer Therapy and Diagnosis (2023) · cites this paper as [161]
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measuredThe cited source doesn’t support the claim as written.
In the citing paper
“Contrary to the EPR mechanism, the frequency of the gaps on the endothelial lining in tumors is too low to account for the NP accumulation in the tumor site, which was observed by TEM analysis [161].”
From Approaches to Improve EPR-Based Drug Delivery for Cancer Therapy and Diagnosis (2023) · cites this paper as [161]
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Several studies have demonstrated that only 0.1 to 0.2% of the injected dose is efficient against tumor cells and exhibits significant anticancer effects [20,123,161].”
From Approaches to Improve EPR-Based Drug Delivery for Cancer Therapy and Diagnosis (2023) · cites this paper as [161]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Therefore, defining the dominant mechanism of the entry of NPs into tumors may help engineer effective delivery carriers to enhance cancer therapy [161].”
From Approaches to Improve EPR-Based Drug Delivery for Cancer Therapy and Diagnosis (2023) · cites this paper as [161]
Experimental — accuracy not yet measured
The cited source says what the claim attributes to it.
In the citing paper
“This study’s outcome is a challenge for the long-established EPR mechanism of drug delivery to solid tumors.”
From Approaches to Improve EPR-Based Drug Delivery for Cancer Therapy and Diagnosis (2023) · cites this paper as [161]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Tumor angiogenesis: therapeutic implications
Sherwood, L. M., Parris, E. E., & Folkman, J. (1971) · New England Journal of Medicine · doi:10.1056/nejm197111182852108 · Cited by 10,187
Bang, Y.-J., Van Cutsem, E., Feyereislova, A., Chung, H. C., Shen, L., Sawaki, A., Lordick, F., Ohtsu, A., Omuro, Y., Satoh, T., et al. (2010) · The Lancet · doi:10.1016/s0140-6736(10)61121-x · Cited by 7,302
Studies of the HER-2/ neu Proto-Oncogene in Human Breast and Ovarian Cancer
Slamon, D. J., Godolphin, W. J., Jones, L. A., Holt, J. A., Wong, S., Keith, D. E., Levin, W. J., Stuart, S. G., Udove, J. A., Ullrich, A., et al. (1989) · Science · doi:10.1126/science.2470152 · Cited by 6,817
Matsumura, Y., & Maeda, H. (1986) · PubMed · Cited by 6,781
Increased Survival in Pancreatic Cancer with nab-Paclitaxel plus Gemcitabine
Von Hoff, D. D., Ervin, T., Arena, F. P., Chiorean, E. G., Infante, J., Moore, M., Seay, T., Tjulandin, S. A., Ma, W. W., Saleh, M. N., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1304369 · Cited by 6,712
Drug combination studies and their synergy quantification using the Chou-Talalay method
Chou, T.-C. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-1947 · Cited by 5,739
Analysis of nanoparticle delivery to tumours
Wilhelm, S., Tavares, A. J., Dai, Q., Ohta, S., Audet, J., Dvorak, H. F., & Chan, W. C. W. (2016) · Nature Reviews Materials · doi:10.1038/natrevmats.2016.14 · Cited by 5,218
Photodynamic therapy of cancer: An update
Agostinis, P., Berg, K., Cengel, K. A., Foster, T. H., Girotti, A. W., Gollnick, S. O., Hahn, S. M., Hamblin, M. R., Juzeniene, A., Kessel, D., et al. (2011) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.20114 · Cited by 5,145
What Is the Evidence That Tumors Are Angiogenesis Dependent?
Folkman, J. (1990) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/82.1.4 · Cited by 4,509
Olive, K. P., Jacobetz, M. A., Davidson, C. J., Gopinathan, A., McIntyre, D., Honess, D., Madhu, B., Goldgraben, M. A., Caldwell, M. E., Allard, D., et al. (2009) · Science · doi:10.1126/science.1171362 · Cited by 3,170
Flagged first, then by citations
1 of the 227 references couldn’t be matched to a known paper.
Research works printed but not linked: 1
- Frei, 1991, Clinical studies of combination chemotherapy for cancer, Synerg. Antagon. Chemother., 1, 103
Cited by
Sorted by citations
Items 601–700 of 1,001
Huang, T., Li, S., Fang, J., Li, F., & Tu, S. (2021) · Bioactive Materials · doi:10.1016/j.bioactmat.2020.12.023 · Cited by 18
Acier, A., Godard, M., Gassiot, F., Finetti, P., Rubis, M., Nowak, J., Bertucci, F., Iovanna, J., Tomasini, R., Lécorché, P., et al. (2021) · Communications Biology · doi:10.1038/s42003-021-02508-0 · Cited by 20
El‐Naggar, M. E., Ali, O. A. A., Saleh, D. I., Abu-Saied, M. A., Ahmed, M., Abdelfattah, E., & Mansour, S. F. (2021) · Journal of Inorganic and Organometallic Polymers and Materials · doi:10.1007/s10904-021-02109-8 · Cited by 18
UV emitting nanoparticles enhance the effect of ionizing radiation in 3D lung cancer spheroids
Tran, T. A., Kappelhoff, J., Jüstel, T., Anderson, R. R., & Purschke, M. (2022) · International Journal of Radiation Biology · doi:10.1080/09553002.2022.2027541 · Cited by 18
Leng, J., Dai, X., Cheng, X., Zhou, H., Wang, D., Zhao, J., Ma, K., Cui, C., Wang, L., & Guo, Z. (2022) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2022.841186 · Cited by 18
Akram, S. M., Al‐Saffar, A. Z., Hadi, N. A., & Akram, S. M. (2022) · Life Sciences · doi:10.1016/j.lfs.2022.121163 · Cited by 18
Engineered Organic Nanorockets with Light‐Driven Ultrafast Transportability for Antitumor Therapy
Feng, A., Cheng, X., Huang, X., Liu, Y., He, Z., Zhao, J., Duan, H., Shi, Z., Guo, J., Wang, S., et al. (2023) · Small · doi:10.1002/smll.202206426 · Cited by 19
Breast cancer nanomedicine market update and other industrial perspectives of nanomedicine
Aulić, S., Marson, D., Laurini, E., Fermeglia, M., & Pricl, S. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-820016-2.00016-1 · Cited by 18
Randárová, E., Kudláčová, J., & Etrych, T. (2020) · Journal of Controlled Release · doi:10.1016/j.jconrel.2020.06.040 · Cited by 18
Manipulating dynamic tumor vessel permeability to enhance polymeric micelle accumulation
Inoue, Y., Matsumoto, Y., Toh, K., Miyano, K., Cabral, H., Igarashi, K., Iwasaki, S., Kataoka, K., & Yamasoba, T. (2020) · Journal of Controlled Release · doi:10.1016/j.jconrel.2020.11.063 · Cited by 18
Exploring the Influence of Different Albumin Binders on Molecular Imaging Probe Distribution
Höltke, C., Grewer, M., Stölting, M., Geyer, C., Wildgruber, M., & Helfen, A. (2021) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.1c00064 · Cited by 18
Basics for Improved Use of Phages for Therapy
Serwer, P., Wright, E. T., Chapa, J. J. D. L., & Gonzales, C. B. (2021) · Antibiotics · doi:10.3390/antibiotics10060723 · Cited by 18
Advanced Drug Delivery Systems
Prajapati, B. G. (2022) · IntechOpen eBooks · doi:10.5772/intechopen.100967 · Cited by 18
Shi, J., Cui, G., Jin, Y., Mi, B., Liu, K., Zhao, L., Bao, K., Lu, Z., Liu, J., Wang, Y., et al. (2024) · Advanced Healthcare Materials · doi:10.1002/adhm.202402474 · Cited by 18
Stimuli‐Responsive Nanocarriers as Active Enhancers of Antitumoral Immunotherapy
Parra‐Nieto, J., de Cárcer, I. A., del Cid, M. A. G., Jiménez‐Falcao, S., Gónzalez‐Larre, J., & Baeza, A. (2024) · Advanced Materials Interfaces · doi:10.1002/admi.202400343 · Cited by 17
Pathophysiology-Driven Approaches for Overcoming Nanomedicine Resistance in Pancreatic Cancer
Nair, S. T., Abhi, C., Kamalasanan, K., Pavithran, K., Unni, A. R., Sithara, M. S., Sarma, M., & Mangalanandan, T. S. (2024) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.4c00801 · Cited by 17
Hyaluronic acid-conjugated lipid nanocarriers in advancing cancer therapy: A review
Zhang, G., Jiang, X. Y., Xia, Y., Qi, P., Li, J., Wang, L., Wang, Z., & Tian, X. (2025) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2025.140146 · Cited by 19
Gabizón, A., Ohana, P., Amitay, Y., Gorin, J., Tzemach, D., Mak, L., & Shmeeda, H. (2021) · Cancer Drug Resistance · doi:10.20517/cdr.2020.87 · Cited by 17
Chen, E., Wang, T., Zhang, J., Zhou, X. Y., Niu, Y., Liu, F., Zhong, Y., Huang, D., & Chen, W. (2021) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2021.787320 · Cited by 17
The Role of Optical Imaging in Translational Nanomedicine
Hesemans, E., Buttiens, K., Manshian, B. B., & Soenen, S. J. (2022) · Journal of Functional Biomaterials · doi:10.3390/jfb13030137 · Cited by 19
Marine-Inspired Drugs and Biomaterials in the Perspective of Pancreatic Cancer Therapies
Fernandes, A. M., Oliveira, C., Reis, R. L., Martins, A. M., & Silva, T. H. (2022) · Marine Drugs · doi:10.3390/md20110689 · Cited by 17
Shahbazi, S., Reiisi, S., Heidari, R., & Raeisi, M. (2023) · Journal of Nanoparticle Research · doi:10.1007/s11051-023-05712-7 · Cited by 17
Novel emerging nano-assisted anti-cancer strategies based on the STING pathway
Li, X., Wang, H., Chen, Y., Li, Z., Liu, S., Guan, W., Lin, Y., Cao, C., Zheng, W., & Wu, J. (2023) · Acta Materia Medica · doi:10.15212/amm-2023-0023 · Cited by 17
Honokiol suppress the PD-L1 expression to improve anti-tumor immunity in lung cancer
Luo, L., Wu, T., Ji, M., Xiang, J., Zou, Y., & Liao, Y. (2024) · International Immunopharmacology · doi:10.1016/j.intimp.2024.112098 · Cited by 17
Longobardi, G., Moore, T. L., Conte, C., Ungaro, F., Satchi‐Fainaro, R., & Quaglia, F. (2024) · Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.1990 · Cited by 19
Martín‐Sabroso, C., Fraguas‐Sánchez, A. I., González, R. R., & Torres‐Suárez, A. I. (2020) · Current Medicinal Chemistry · doi:10.2174/0929867327666200819115403 · Cited by 17
Wi, T. I., Won, J. E., Lee, C. M., Lee, J., Kang, T. H., Shin, B. C., Han, H. D., & Park, Y. (2020) · International Journal of Nanomedicine · doi:10.2147/ijn.s272319 · Cited by 18
Zhang, Q., Li, D., Zhong, J., Wu, Y., Shi, Y., Yang, H., Zhao, L., Yang, K., & Lin, J. (2020) · Biomaterials Science · doi:10.1039/d0bm02037k · Cited by 17
Estupiñán, Ó., Rendueles, C., Suárez, P., Rey, V., Murillo, D., Morís, F., Gutiérrez, G., Blanco‐López, M. C., Matos, M., & Rodrı́guez, R. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10071358 · Cited by 17
Nanomaterials responding to microwaves: an emerging field for imaging and therapy
Wilson, A. J., Rahman, M. W., Kosmas, P., & Thanou, M. (2021) · Nanoscale Advances · doi:10.1039/d0na00840k · Cited by 17
Background to the ANDRILL McMurdo Ice Shelf Project (Antarctica) and Initial Science Volume
Naish, T., Powell, R. D., & Levy, R. (2007) · Lincoln (University of Nebraska) · Cited by 17
Ghosh, R., Kumar, M., Kumar, S., Komal, K., Sharma, R. R., & Kurmi, B. D. (2025) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2025.108442 · Cited by 18
Jeong, J., Cho, H., Moon, Y., Shim, N., Kim, J., Kim, J., Choi, S.-C., Park, J. Y., Kim, Y., & Kim, K. (2025) · Advanced Materials · doi:10.1002/adma.202516974 · Cited by 16
Carbohydrate Systems in Targeted Drug Delivery: Expectation and Reality
Shchegravina, E. S., Sachkova, A. A., Usova, S. D., Nyuchev, A. V., Gracheva, Y. A., & Fedorov, A. Y. (2021) · Russian Journal of Bioorganic Chemistry · doi:10.1134/s1068162021010222 · Cited by 16
Brummelhuis, I. S. G., Simons, M., Lindner, L. H., Kort, S., de Jong, S., Hossann, M., Witjes, J. A., & Oosterwijk, E. (2021) · International Journal of Hyperthermia · doi:10.1080/02656736.2021.1983038 · Cited by 16
Multimodal imaging distribution assessment of a liposomal antibiotic in an infectious disease model
Cheng, S., Groseclose, M. R., Mininger, C., Bergström, M., Zhang, L., Lenhard, S. C., Skedzielewski, T., Kelley, Z. D., Comroe, D., Hong, H., et al. (2022) · Journal of Controlled Release · doi:10.1016/j.jconrel.2022.08.061 · Cited by 15
Palange, A. L., Mascolo, D. D., Ferreira, M. F. M. M., Gawne, P. J., Spanò, R., Felici, A., Bono, L., Moore, T. L., Salerno, M., Armirotti, A., et al. (2023) · Advanced Science · doi:10.1002/advs.202205223 · Cited by 18
He, P., Dai, Q., & Wu, X. (2023) · Environmental Research · doi:10.1016/j.envres.2023.115672 · Cited by 16
Yan, X., Li, S., Yan, H., Yu, C., & Liu, F. (2023) · International Journal of Nanomedicine · doi:10.2147/ijn.s399047 · Cited by 17
Toll-like receptor-targeted nanoparticles: A powerful combination for tumor immunotherapy
Zhi, X., Yang, P., Xu, Y., Dai, Z., Yue, X., & Qian, L. (2023) · Nano Today · doi:10.1016/j.nantod.2023.102003 · Cited by 17
Yan, W., Li, Y., Zou, Y., Zou, Y., Wu, T., Yuan, W., Lang, T., Li, Y., & Yin, Q. (2023) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2023.123583 · Cited by 16
Yokoe, I., Omata, D., Unga, J., Suzuki, R., Maruyama, K., Okamoto, Y., & Osaki, T. (2021) · Drug Delivery · doi:10.1080/10717544.2021.1895907 · Cited by 16
Delivery of siRNA Using Functionalized Gold Nanorods Enhances Anti-Osteosarcoma Efficacy
Zhang, M., Lin, J., Jin, J., Yu, W., Qi, Y., & Tao, H. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.799588 · Cited by 16
Yin, C., Wang, S., Ren, Q., Shen, X., Chen, X., Liu, Y., & Liu, S. (2019) · 中国科学通报：英文版 · doi:10.1016/j.scib.2019.04.017 · Cited by 16
Orienti, I., Nguyen, F., Guan, P. F., Kolla, V., Calonghi, N., Farruggia, G., Chorny, M., & Brodeur, G. M. (2019) · Drug Design Development and Therapy · doi:10.2147/dddt.s221909 · Cited by 16
Haddad, Y., Charousová, M., Zivotska, H., Šplíchal, Z., Rodrigo, M. Á. M., Michalkova, H., Křížková, S., Tesařová, B., Richtera, L., Vítek, P., et al. (2020) · Journal of Nanobiotechnology · doi:10.1186/s12951-020-00654-x · Cited by 16
Zhang, J., Zhan, B., Du, Y., Liu, N., Liu, S., & Li, X. (2025) · Industrial Crops and Products · doi:10.1016/j.indcrop.2025.121704 · Cited by 17
Lin, D., Huang, W., Yang, H., Zhu, J., Liu, Y., Wang, L., Yan, D., Wang, D., & Tang, B. Z. (2025) · Advanced Materials · doi:10.1002/adma.202510493 · Cited by 16
Phototheranostics Using Erythrocyte-Based Particles
Hanley, T., Vankayala, R., Lee, C.-H., Tang, J. C., Burns, J. M., & Anvari, B. (2021) · Biomolecules · doi:10.3390/biom11050729 · Cited by 15
Izci, M., Maksoudian, C., Goncalves, F. R., Aversa, L., Salembier, R., Sargsian, A., Gilabert, I. P., Chu, T., Ríos‐Luci, C., Bolea‐Fernandez, E., et al. (2022) · Journal of Nanobiotechnology · doi:10.1186/s12951-022-01727-9 · Cited by 17
Liu, Y., Sebastian, S., Huang, J., Corbascio, T., Engellau, J., Lidgren, L., Tägil, M., & Raina, D. B. (2022) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2022.1076320 · Cited by 15
Winter, G., Eberhardt, N., Löffler, J., Raabe, M., Alam, M. N. A., Li, H., Abaei, A., Herrmann, H., Kuntner, C., Glatting, G., et al. (2022) · Nanomaterials · doi:10.3390/nano12244471 · Cited by 15
Cao, G., Cao, W., Zhang, J., Chen, Q., Chen, J., Chu, Q., Sun, Q., Xiong, M., Chen, B., & Li, X. (2023) · Nano Research · doi:10.1007/s12274-022-5301-7 · Cited by 15
Islam, M. R., Patel, J., Back, P. I., Shmeeda, H., Kallem, R. R., Shudde, C. E., Markiewski, M. M., Putnam, W. C., Gabizón, A., & La-Beck, N. M. (2023) · Biomolecules · doi:10.3390/biom13091309 · Cited by 15
Recent Update on Nanocarrier(s) as the Targeted Therapy for Breast Cancer
Mukherjee, D., & Raikwar, S. (2024) · AAPS PharmSciTech · doi:10.1208/s12249-024-02867-x · Cited by 15
Enhancing tumor endothelial permeability using MUC18-targeted gold nanorods and mild hyperthermia
Yu, X., Liu, J., Bauer, A., Wei, X., Smith, S., Ning, S., & Wang, C. (2024) · Journal of Colloid and Interface Science · doi:10.1016/j.jcis.2024.07.047 · Cited by 15
Steroidal saponins: Natural compounds with the potential to reverse tumor drug resistance (Review)
Cui, A., Liu, H., Liu, X., Zhang, M., Xiao, B., Wang, B., & Yang, J. (2024) · Oncology Letters · doi:10.3892/ol.2024.14719 · Cited by 18
Kawasaki, R., Eto, T., Kono, N., Ohdake, R., Yamana, K., Hirano, H., Kawamura, S., Tarutani, N., Katagiri, K., & Ikeda, A. (2024) · Biomaterials Science · doi:10.1039/d4bm00769g · Cited by 15
Alradwan, I. A., Zhi, P., Zhang, T., Lip, H., Zetrini, A., He, C., Henderson, J. T., Rauth, A. M., & Wu, X. Y. (2024) · Journal of Controlled Release · doi:10.1016/j.jconrel.2024.11.061 · Cited by 15
Nanoparticles in nuclear medicine: From diagnostics to therapeutics
Wang, Y., Barmin, R. A., Mottaghy, F. M., Kiessling, F. M., Lammers, T., & Pallares, R. M. (2025) · Journal of Controlled Release · doi:10.1016/j.jconrel.2025.113815 · Cited by 15
Targeted hyperthermia with plasmonic nanoparticles
Vilches, C., & Quidant, R. (2020) · Frontiers of nanoscience · doi:10.1016/b978-0-08-102828-5.00012-7 · Cited by 15
Taresco, V., Abelha, T. F., Cavanagh, R. J., Vasey, C. E., Anane‐Adjei, A. B., Pearce, A. K., Monteiro, P. F., Spriggs, K. A., Clarke, P. A., Ritchie, A., et al. (2020) · Advanced Therapeutics · doi:10.1002/adtp.202000103 · Cited by 19
Wang, X., Deng, B., Yu, M., Zeng, T., Chen, Y., Hu, J., Wu, Q., & Li, A. (2021) · Biomaterials Science · doi:10.1039/d1bm01246k · Cited by 15
Pegylated liposomal mitoxantrone modulates tumor immune landscape to boost PD-L1 blockade therapy
Huang, M., Wang, S., Chen, S., Wang, J., Xu, C., Liu, J., Lian, Z., Du, X., & Wang, J. (2022) · Nano Today · doi:10.1016/j.nantod.2022.101500 · Cited by 15
Malinovskaya, J. A., Salami, R., Valikhov, M. P., Vadekhina, V. V., Semyonkin, A. S., Semkina, A. S., Abakumov, M. A., Harel, Y., Levy, E., Levin, T., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms24010627 · Cited by 16
Gan, L., Lin, X., Zhong, Z., Zheng, Y., Chen, X., Chen, J., Xiao, Y., Liu, Y., Pan, X., Wu, C., et al. (2025) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2025.09.043 · Cited by 15
Graphene-based nanomaterials for cancer therapy
Sachdeva, H., Khandelwal, A. R., Meena, R., Sharma, K., & Khatik, N. (2021) · Materials Today Proceedings · doi:10.1016/j.matpr.2021.01.314 · Cited by 14
Jia, Y., Taledaohan, A., Jia, R., Wang, X., Jia, Y., Liu, J., & Wang, Y. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.115826 · Cited by 14
Shi, Q., Zhang, X., Wu, M., Xia, Y., Pan, Y., Weng, J., Li, N., Zan, X., & Xia, J. (2023) · Materials Today Bio · doi:10.1016/j.mtbio.2023.100873 · Cited by 14
Engineered oncolytic bacteria for malignant solid tumor treatment
Wang, M., Song, X., Liu, X., Ma, C., Ma, J., & Shi, L. (2024) · Interdisciplinary medicine · doi:10.1002/inmd.20240005 · Cited by 16
Kopec̆ek, J. (2024) · Journal of Controlled Release · doi:10.1016/j.jconrel.2024.05.012 · Cited by 14
Borisenkova, A. A., Bolshakova, O. I., Titova, A. V., Ryabokon, I. S., Markova, M. A., Lyutova, Z. B., Sedov, V. P., Varfolomeeva, E. Y., Bakhmetyev, V. V., Arutyunyan, A. V., et al. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25105350 · Cited by 14
Functionalised Ligand-Based Nanomaterial Drug Targeting Approaches for Colorectal Cancer Therapy
Dixit, A. A., Mandlik, D. S., & Mandlik, S. K. (2024) · Recent Advances in Drug Delivery and Formulation · doi:10.2174/0126673878301004240703073107 · Cited by 14
Atypical artificial cells: Novel biomimetic materials for combating cancer
Ren, Z., Wan, Q., Zhu, Y., Li, L., Wang, K., Zhao, F., Jiao, K., Tang, M., Tay, F. R., Wan, M., et al. (2024) · Interdisciplinary materials · doi:10.1002/idm2.12199 · Cited by 15
Combined Photothermal Chemotherapy for Effective Treatment Against Breast Cancer in Mice Model
Chen, J., Xiang, Y., Bao, R., Zheng, Y., Fang, Y., Feng, J., Wu, D., & Chen, X. (2024) · International Journal of Nanomedicine · doi:10.2147/ijn.s473052 · Cited by 15
Advancements in colorectal cancer immunotherapy: from CAR-T cells to exosome-based therapies
Arabi, S., Fadaee, M., Kazemi, T., & Rahmani, M. R. (2025) · Journal of drug targeting · doi:10.1080/1061186x.2024.2449482 · Cited by 16
Varani, M., Galli, F., Capriotti, G., Mattei, M., Cicconi, R., Campagna, G., Panzuto, F., & Signore, A. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9061750 · Cited by 14
Robb, R. N., Kuo, J. C., Liu, Y., Corrales-Guerrero, S., Cui, T., Hegazi, A., Nagy, G., Lee, R. J., & Williams, T. M. (2021) · Molecular Therapy — Oncolytics · doi:10.1016/j.omto.2021.07.013 · Cited by 14
Advances and applications of monoolein as a novel nanomaterial in mitigating chronic lung diseases
Chan, Y., Singh, S. K., Gulati, M., Wadhwa, S., Prasher, P., Kumar, D., Kumar, A. P., Gupta, G., Kuppusamy, G., Haghi, M., et al. (2022) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2022.103541 · Cited by 18
Kaurenoic acid nanocarriers regulates cytokine production and inhibit breast cancer cell migration
Ferreira, K. C. B., Valle, A. B. C. D. S., Gualberto, A. C. M., Aleixo, D. T., Silva, L. M., Santos, M. M., Costa, D. D. S., Oliveira, L. L., Gameiro, J., Tavares, G. D., et al. (2022) · Journal of Controlled Release · doi:10.1016/j.jconrel.2022.10.048 · Cited by 14
Organosilica Nanoparticles and Medical Imaging
Nakamura, M. (2018) · The Enzymes · doi:10.1016/bs.enz.2018.08.002 · Cited by 14
FUJII, H., Horie, S., Sukhbaatar, A., Mishra, R., Sakamoto, M., Mori, S., & Kodama, T. (2019) · Cancer Medicine · doi:10.1002/cam4.2125 · Cited by 14
Tumor in 3D: In Vitro Complex Cellular Models to Improve Nanodrugs Cancer Therapy
Fernandes, S., Cassani, M., Pagliari, S., Filipenský, P., Cavalieri, F., & Forte, G. (2020) · Current Medicinal Chemistry · doi:10.2174/0929867327666200625151134 · Cited by 15
Lei, Y., Xiao, T., Hu, X., & Lin, H. (2026) · Drugs in R&D · doi:10.1007/s40268-026-00538-9 · Cited by 14
Hama, S., Nishi, T., Isono, E., Itakura, S., Yoshikawa, Y., Nishimoto, A., Suzuki, S., Kirimura, N., Todo, H., & Kogure, K. (2022) · Cancer Science · doi:10.1111/cas.15321 · Cited by 13
Optical spectroscopy and imaging in surgical management of cancer patients
Wilson, B. C., & Eu, D. (2022) · Translational Biophotonics · doi:10.1002/tbio.202100009 · Cited by 13
Ling, J., Jiang, Y., Yan, S., Dang, H., Yue, H., Liu, K., Kuang, L., Liu, X., & Tang, H. (2022) · Cancer Nanotechnology · doi:10.1186/s12645-022-00139-6 · Cited by 13
Targeted delivery of liposomal chemoimmunotherapy for cancer treatment
Liu, Y., Han, J., Yang, B., Bhatta, R., & Wang, H. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1010021 · Cited by 16
Xin, Y., Wang, L.-Y., Chang, H., Ma, F.-H., Sun, M., Chen, L., & Gao, H. (2022) · Chinese Journal of Polymer Science · doi:10.1007/s10118-023-2890-x · Cited by 14
Singh, S., Singh, G., Attri, S., Kaur, P., Rashid, F., Bedi, N., Haque, S., Janahi, E. M. A., & Arora, S. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.1080977 · Cited by 13
Ravi, H., Arias, A., Costello, J. R., Han, H. S., Jeong, D. K., Klinz, S. G., Sachdev, J. C., Korn, R. L., & Raghunand, N. (2023) · Radiology Imaging Cancer · doi:10.1148/rycan.220022 · Cited by 13
Nanomedicines: intervention in inflammatory pathways of cancer
Anwar, F., Naqvi, S., Shams, S., Sheikh, R. A., Al-Abbasi, F. A., Asseri, A. H., Baig, M. R., & Kumar, V. (2023) · Inflammopharmacology · doi:10.1007/s10787-023-01217-w · Cited by 13
Targeted Radium Alpha Therapy in the Era of Nanomedicine: In Vivo Results
Trencsényi, G., Csikos, C., & Képes, Z. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25010664 · Cited by 13
Moving beyond traditional therapies: the role of nanomedicines in lung cancer
Zhang, J., Li, Y., Guo, S., Zhang, W., Fang, B., & Wang, S. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1363346 · Cited by 16
mRNA Sonotransfection of Tumors with Polymeric Microbubbles: Co‐Formulation versus Co‐Administration
Chen, J., Wang, B., Wang, Y., Radermacher, H., Qi, J., Momoh, J., Lammers, T., Shi, Y., Rix, A., & Kiessling, F. M. (2024) · Advanced Science · doi:10.1002/advs.202306139 · Cited by 13
Li, M., Li, T., Wu, F., Ren, F. Z., Xue, S., & Li, C. (2024) · Chemosensors · doi:10.3390/chemosensors12060113 · Cited by 13
Gao, Y., Huang, Y., Zhang, Q., Yang, H., Li, Y., Li, Y., Zhou, M., Yang, R., Xu, B., Liu, L., et al. (2025) · Cancer · doi:10.1002/cncr.35672 · Cited by 13
Microfluidic Reconstitution of Tumor Microenvironment for Nanomedical Applications
Oh, H. J., Kim, J., Kim, H., Choi, N., & Chung, S. H. (2021) · Advanced Healthcare Materials · doi:10.1002/adhm.202002122 · Cited by 13
Wang, X., He, J., Jiang, S., Gao, Y., Zhang, L., Yin, L., You, R., & Guan, Y. (2021) · Journal of Materials Chemistry B · doi:10.1039/d1tb02056k · Cited by 13
Giorgio, E. D., Ferino, A., Choudhary, H., Löffler, P. M. G., D’Este, F., Rapozzi, V., Tikhomirov, A. S., Shchekotikhin, A. E., Vogel, S., & Xodo, L. E. (2022) · Journal of Photochemistry and Photobiology B Biology · doi:10.1016/j.jphotobiol.2022.112449 · Cited by 13
Metadata
- Authors
- Golombek, S. K., May, J.-N., Theek, B., Appold, L., Drude, N., Kiessling, F., & Lammers, T.
- Affiliations
- Universitätsklinikum Aachen (DE)
- Utrecht University (NL)
- Corresponding author
- Lammers, Twan
- Venue
- Advanced Drug Delivery Reviews
- Publisher
- Elsevier BV
- Published
- 2018-05
- Volume
- 130
- Pages
- 17-38
- ISSN
- 0169-409X (ISSN-L)
- PMC
- PMC6130746
- OpenAlex
- W2884616676
- Cited by
- 1,262
- References
- 227
- Citations by year
- 2026: 118 · 2025: 115 · 2024: 121 · 2023: 124 · 2022: 200 · 2021: 261 · 2020: 221 · 2019: 93 · 2018: 7
- FWCI
- 9.62
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Advanced Drug Delivery Reviews (publishedVersion)
- PubMed (publishedVersion)
- University of Twente Research Information (publishedVersion, cc-by-nc-nd)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- RWTH Publications (RWTH Aachen) (submittedVersion)
- University of Twente Research Information (submittedVersion, cc-by-nc-nd)
- Funders
- European Research Council (309495, 680882, 813086)
- German research Foundation (La2937/1-2, SFB/TRR57, SFB1066, GRK2375)
- European Union
- Topics
- Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
- Physical Sciences › Engineering › Biomedical Engineering › Nanoplatforms for cancer theranostics
- Physical Sciences › Engineering › Biomedical Engineering › Ultrasound and Hyperthermia Applications
- Keywords
- enhanced permeability and retention effect, tumor targeting, nanomedicine, tumor heterogeneity, precision oncology, tumor imaging, tumor accumulation
- MeSH terms
- Antineoplastic Agents, Humans, Neoplasms, Permeability, Drug Delivery Systems, Nanomedicine
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
